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The aim of this study was to determine the prevalence and clinical characteristics of epilepsy and seizure disorders in Bradford.
The method used was a community-based cross-sectional study. Case ascertainment was by review of medical records iden-
tified by searching practice databases using diagnostic codes and from repeat prescribing data. A specialist epilepsy nurse
reviewed the records in 39 practices covering a population of 225 439. Clinical review was undertaken where there was limited
information available in the records.
In total, 1643 cases of epilepsy were identified (prevalence 7.3/1000). The prevalence of epilepsy increased with age. Classifi-
cation of patients by internationally agreed definitions showed 1013 (62%) of cases with active epilepsy (prevalence 4.5/1000);
421 (26%) with epilepsy in remission on treatment and 209 (13%) with epilepsy in remission off treatment. The standardized
rate for all patients of South Asian origin was 3.6/1000 compared to 7.8/1000 in the rest of the population (OR 0.46; 95%
CI 0.38, 0.57). An underlying aetiology was identified in 29.5% of cases. Cerebrovascular disease and head injuries were the
commonest causes.
Conclusions: The prevalence of epilepsy supports previous epidemiological estimates and highlights the public health impor-
tance of epilepsy. The low prevalence in the South Asian population is a surprising finding and further research into cultural
attitudes to epilepsy and the impact of stigma in the South Asian population in the UK is required.
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Epilepsy is the most common serious neurological
condition1. Epidemiological data are important not
only to improve our understanding about the condition
and its aetiology, but also to allow a rational approach
to planning health services which meet health needs2.
We undertook a community-based study to deter-
mine the prevalence of epilepsy and seizure disorders
in Bradford.
MATERIALS AND METHODS
The study was undertaken between 1996 and 1998 in
an urban primary care setting in Bradford, England.
Bradford is a manufacturing city with a large South
Asian† population and comparatively high indices of
deprivation. There are 83 general practices covering
a population of 360 000. The South Asian population
comprises 87 300 people (24% of the population), of
whom 80% are of Pakistani origin.
All practices were invited to participate in the study.
Case ascertainment was by review of the medical
records. Cases were identified using two methods:
(1) searching of computerized practice databases using
all diagnostic terms and codes for epilepsy and seizure
disorders; (2) searching of prescribing data for 12 an-
ticonvulsant drugs (carbamazepine, sodium valproate,
phenytoin, phenobarbitone, lamotrigine, clobazam,
primidone, gabapentin, clonazepam, vigabatrin, topi-
ramate, ethosuximide).
A specialist epilepsy nurse then reviewed the medi-
cal records of all cases identified, consulting with the
† South Asians refers to people who were born in or originate from the Indian subcontinent.
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general practitioner when necessary to clarify details.
Information was recorded on a data extraction form.
Where there was doubt over the diagnosis or treat-
ment, or where there was only limited information
available in the records, the patient was invited for re-
view by a neurologist in an epilepsy clinic.
Internationally agreed case definitions were used to
classify categories of epilepsy and seizure type3.
The following information was collected: demo-
graphic details; seizure type and frequency; medica-
tion; aetiology and co-morbidity.
Analysis
Collation of data and descriptive analysis was under-
taken using Access software. South Asian ethnicity
was identified using Nam Pehchan, a validated soft-
ware programme used to identify South Asian names
and their religious and linguistic origin, and manual
checks of patients’ names.
Prevalence was calculated as a point prevalence at
the end of the ascertainment period with patients con-
sidered prevalent if they were alive and resident in the
district on 1st November 1998. Direct standardization
of prevalence rates was carried out using the European
Standard population. Confidence intervals were calcu-
lated using Confidence Interval Analysis software, but
not for prevalence rates as we were not considering a
randomly selected sample. Case ascertainment is the
main potential source of bias in our study.
RESULTS
Thirty-nine practices (47%) agreed to participate, cov-
ering a population of 225 439 (63% of the total pop-
ulation). There was a lower proportion of inner-city
primary care group practices (36% vs. 66%, OR 0.30,
95% CI 0.12, 0.71) in participating practices. Inner-
city practices tended to cover smaller practice popula-
tions (70% under 5000 population list size) and 50%
were single-handed general practitioners.
Prevalence
There were 1991 possible cases identified from
searches of the medical records. Of these, 542 (27.2%)
patients were invited for review by the neurologist be-
cause of diagnostic uncertainty or lack of informa-
tion in the records; 382 (70.5%) of these patients at-
tended the epilepsy clinic and 152 (7.6%) cases were
found not to have a diagnosis of epilepsy. For 122
(6.1%) patients the diagnosis of epilepsy was doubtful
and non-epileptic events considered responsible and
74 (3.7%) patients were diagnosed as having had a sin-
gle seizure.
In 1643 (84%) of cases a diagnosis of epilepsy
was either confirmed by record review or neurologi-
cal assessment (prevalence 7.3/1000). Classification of
patients by internationally agreed definitions showed
1013 (62%) of cases with active epilepsy (prevalence
4.5/1000); 421 (26%) with epilepsy in remission on
treatment and 209 (13%) with epilepsy in remission
off treatment.
Information about the type of seizure was recorded
in the medical records or obtained at review for 1561
(95.0%) patients (Table 1); 156 (17.8%) patients had
two seizure types recorded, and 22 (3.0%) had three
seizure types.
In addition, 1140 (69.4%) of cases had been investi-
gated by EEG, 693 (42.2%) had undergone a CT scan
and 55 (3.4%) an MRI.
Demography
Eight hundred and thirty-one (51.1%) of cases were
male and 101 (6.2%) of cases were of South Asian ori-
gin. Figure 1 shows the age standardized rates by eth-
nicity. The standardized rate for all patients of South
Asian origin was 3.6/1000 compared to 7.8/1000 in the
rest of the population (OR 0.46; 95% CI 0.38, 0.57).
Aetiology
Table 2 shows the aetiology of epilepsy. Cerebrovas-
cular disease and head injuries were the common-
est causes identified. Two hundred and seventy-three
(16.6%) of cases had learning disabilities although the
relationship with epilepsy and congenital or perina-
tal aetiological factors could not be determined from
recorded information.
Two hundred and twenty-seven (13.8%) of cases had
a family history (first degree relatives) of epilepsy.
Treatment
Of those patients currently on treatment with anticon-
vulsant drugs, 1109 (69.5%) were on single drug treat-
ment, 389 (24.4%) were taking two, 81 (5.1%) three,
and 16 (1%) four anticonvulsant drugs. Table 3 shows
the frequency of anticonvulsant drug prescribing.
DISCUSSION
This community-based study is one of the largest epi-
demiological studies of epilepsy undertaken in the
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Table 1: Seizure type.
Seizure Primary (%) Secondary Tertiary
Generalized Primary generalized 181 (11.6) 13
Tonic 12 (0.8) 4 2
Absence 25 (1.6) 22 5
Atypical absence 28 (1.8) 11 3
Atonic 15 (1) 8 5
Myoclonic 50 (3.2) 23 6
Tonic–clonic 741 (47.5) 72 9
Partial Partial 37 (2.4) 23 1
Simple partial 34 (2.2) 15 4
Complex partial 328 (21) 42 4
Secondary generalized 110 (7.1) 44 7
Prevalence of epilepsy in Bradford (Odds ratios, 95% confidence intervals)
OR 0.12
(0.03, 0.49)
OR 0.05
(0.01, 0.33)OR 0.36
(0.19, 0.71)
OR 0.80
(0.53, 1.20)
OR 0.30
(0.17, 0.54)
OR 0.80
(0.57, 1.13)
OR 0.57
(0.39, 0.84)
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Fig. 1: Prevalence of epilepsy in Bradford (odds ratios, 95% confidence intervals).
United Kingdom. Three types of bias are important
to consider for a study that relied predominantly on
medical records as a source of case ascertainment
and information: recruitment, case ascertainment and
recording.
There was an under-representation of inner-city pri-
mary care group practices recruited. These are com-
monly single-handed, small practices where limited
research access might be anticipated. This under-
representation is particularly important when consid-
ering the validity of the results of the effect of eth-
nicity on prevalence. The majority (89%) of patients
of South Asian origin are registered in these practices.
However, 77% of South Asian patients included in this
study came from the inner-city primary care group and
there is no reason to expect that they are different from
the total South Asian population in Bradford.
Case ascertainment was through searching records
by diagnostic codes and prescribing information. Lim-
itations in the recording of diagnostic terms and
codes, particularly in patients with epilepsy in remis-
sion off treatment, are likely to have led to under-
ascertainment of these patients. However, the use of
prescribing information will have provided accurate
prevalence rates for patients with active epilepsy and
epilepsy in remission on treatment.
Recording bias was minimized by having a trained
epilepsy nurse to abstract information and expert re-
view from a neurologist in cases where there was
uncertainty. Under-recording of clinical information
such as aetiology and family history in medical
records may reduce the validity of these data. Ide-
ally in an epidemiological study of epilepsy, all cases
would have been interviewed to confirm the diagno-
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Table 2: Aetiology of epilepsy.
Aetiology Number of patients (%)
Idiopathic/cryptogenic 704 (59.2)
Trauma 135 (11.4)
Vascular 119 (10.0)
Previous febrile episode 63 (5.3)
Neoplastic 44 (3.7)
Multiple factors 43 (3.6)
Infection 27 (2.3)
Intracerebral bleed 27 (2.3)
Toxic (drugs/alcohol) 16 (1.3)
Post-neurosurgical 11 (0.9)
Table 3: Prescribing of anticonvulsant drugs.
Medication Number of patients (% of total prescribing)
Carbamazepine 715 (33.5)
Sodium valproate 630 (29.5)
Phenytoin 339 (15.9)
Phenobarbitone 143 (6.7)
Lamotrigine 97 (4.6)
Clobazam 59 (2.8)
Primidone 41 (1.9)
Gabapentin 31 (1.4)
Clonazepam 29 (1.4)
Vigabatrin 24 (1.1)
Topiramate 14 (0.6)
Ethosuximide 12 (0.6)
sis and risk factors. This was not practical in such a
large study. However nearly one quarter of patients
were reviewed by a neurologist and these were the
cases where there was limited information in the med-
ical records.
Prevalence
Previous studies have reported a wide range of preva-
lence rates for epilepsy1, 4. Much of this variation will
be due to problems with diagnosis and case ascertain-
ment in the different methods used, and variation in
definitions adopted. Our prevalence rate of 4.5/1000
for active epilepsy and 6.3/1000 for treated epilepsy is
in line with previous estimates from the United King-
dom which range from 4.2–5.3/10005–8. Age stan-
dardized rates demonstrate increasing prevalence with
increasing age, supporting previous findings4, 8.
Nearly 10% of patients on anticonvulsant drugs had
a diagnosis of epilepsy refuted either because of non-
epileptic events or single seizures. Although the clini-
cal review provided the opportunity to stop treatment,
very few patients have agreed, either because of anx-
iety over occurrence of seizures after withdrawal, or
from habit. Research is being undertaken to explore
this finding further.
One unexpected result was the low prevalence of
epilepsy in the South Asian population. A number of
possible explanations exist for the low prevalence ob-
served in the South Asian population. The difference
may be real. However this is not supported from other
studies9, and has little biological plausibility, partic-
ularly in view of the higher incidence of cerebrovas-
cular disease in South Asians. The difference may
be due to selective migration. The majority of South
Asians over 25 years were born outside the UK10 and
this might explain the lower prevalence observed in
the older age groups. However it does not explain the
differences (albeit smaller) observed in the younger
adults.
The difference may reflect the stigma attached to
epilepsy11 and subsequent denial and unwillingness to
seek medical treatment, particularly by older patients
or parents. The lower difference in the 25–34 age
group may be due to young adults becoming confident
enough to seek treatment for employment or social
reasons. The only previous study looking at stigma-
tization in Pakistan was unable to establish its impor-
tance, but this may have been due to the reliance on
an unvalidated, self-reported questionnaire rather than
more in-depth qualitative research that may have been
required to explore this issue12.
The difference may reflect inadequate medical man-
agement due to poor communication. Epilepsy is pri-
marily a clinical diagnosis. Where communication is
poor between patient and doctor, and the doctor fails
to take an adequate history, then the diagnosis may
be missed. This again may be more marked in older
patients where English is not their first language.
Classification and aetiology
Seizure classification in epidemiological studies is no-
toriously difficult as recording is often unreliable and
EEG confirmation impractical and even in hospital
practice around a third of cases are unclassifiable13.
Previous international studies have found that around
half of cases are partial epilepsy and half generalized4.
In the United Kingdom a previous study in primary
care found that 52% of patients had partial seizures,
39% generalized and 9% unclassifiable14. The propor-
tion of patients with partial seizures in this study was
low (33%). This may reflect the recording and classi-
fication biases inherent in the study methodology.
Only 30% of cases of epilepsy had a definite aeti-
ology, a finding backed up by previous international
and UK studies1, 14. The reliance on general prac-
tice records rather than direct review of neuroimaging
and EEG results may underestimate the proportion of
cases with known causative factors.
Estimating prescribing patterns from market share
is complicated by the lack of linkage between pre-
scribing information and diagnosis. Several of the an-
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ticonvulsant drugs have other prescribing indications.
Our data confirm national market share data about the
top three drugs being carbamazepine (36% nationally,
34% in Bradford), sodium valproate (24% nationally,
30% in Bradford) and phenytoin (22% nationally, 16%
in Bradford) (IMS Health personal communication,
1998 data). Differences may reflect local prescribing
trends and improved accuracy of data linked to diag-
nosis.
CONCLUSIONS
This large population study adds to our knowledge of
the prevalence, demography, aetiology and treatment
of epilepsy and seizure disorders in the United King-
dom. Previous prevalence and frequency estimates are
supported by our results that demonstrate the public
health importance of epilepsy. The low prevalence of
epilepsy in the South Asian population is a surprising
result and one that prompts concern about the equity
of service provision. Further research is required into
cultural attitudes to epilepsy and the impact of stigma.
A high diagnostic index of suspicion for the possibility
of epilepsy in South Asian patients may be warranted
in view of the potential for missed diagnoses due to
poor communication.
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